AzTrials
AzTrials

Sleep DeprivationNCT07314645

Strategic Daytime Napping Enhances Agility and Lowers Perceived Exertion But Does Not Improve Fatigue Resistance in Adolescent Soccer Players

A study testing Pro Agility Test, Repeated-Sprint Ability (RSA) Test and Rate of Perceived Exertion (RPE) in people with Sleep Deprivation and Athletic Performance, run by Uludag University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Daytime napping is increasingly incorporated into athletic recovery routines to manage sleepiness and support alertness. However, the effects of different nap durations on high-intensity anaerobic performance tasks remain insufficiently characterized, particularly in team-sport settings. Read more about this study

Who is it for?
Ages 16 to 19 years, men only
Conditions the study is for
Sleep Deprivation, Athletic Performance, Fatigue
What is being tested?
Pro Agility Test, Repeated-Sprint Ability (RSA) Test and Rate of Perceived Exertion (RPE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 May 2024to 18 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 19 years
  • Men only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • being a member of the Yeni Malatyaspor U19 or U17 team
  • having no history of illness or injury
  • no regular napping habit

Who cannot join

  • active infections
  • hyperactivity
  • sleep disorders
  • sleep problems on protocol days

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Inonu University

    Malatya, Malatya, 44000

Other trials in Turkey (Türkiye)

About this study

Background

Daytime napping is increasingly incorporated into athletic recovery routines to manage sleepiness and support alertness. However, the effects of different nap durations on high-intensity anaerobic performance tasks remain insufficiently characterized, particularly in team-sport settings. Nap duration and circadian timing may influence psychomotor readiness, perceived exertion, and fatigue-related responses, yet existing evidence is limited and inconsistent in adolescent athlete populations. This study is designed to examine the acute effects of two daytime nap durations within a controlled experimental framework.

Read more

Methods

This study will employ a randomized, crossover design involving sixteen competitive male adolescent soccer players classified as intermediate chronotypes. Each participant will complete three experimental conditions in a randomized order: no nap (N0), a 25-minute nap (N25), and a 45-minute nap (N45), with standardized washout periods between sessions. Nap compliance will be objectively monitored using wrist-worn actigraphy.

Following each condition, participants will observe a standardized 60-minute post-nap wakefulness period prior to performance testing. Agility performance will be assessed using the Pro Agility Test, and anaerobic endurance will be evaluated using a repeated-sprint ability (RSA) protocol. Psychophysiological measures will include ratings of perceived exertion (RPE), the Hooper Index, visual analogue scales (VAS) for subjective alertness, and mood states assessed via the Profile of Mood States (POMS). These outcomes will be collected to compare responses across nap conditions.

Objectives

The primary objective of this study is to compare the acute effects of two daytime nap durations (25 minutes vs 45 minutes) on agility performance in adolescent soccer players without a habitual napping routine. Secondary objectives include examining nap-related differences in repeated-sprint performance indices, perceived exertion, subjective alertness, and mood states.

Keywords

daytime nap; athletic recovery; agility; repeated-sprint ability; perceived exertion; mood; chronotype

Being tested
Pro Agility Test, Repeated-Sprint Ability (RSA) Test, Rate of Perceived Exertion (RPE)
Keywords
Daytime Napping, Sleep Inertia, Perceived Exertion, Mood State, Agility, Repeated Sprint Ability, Chronotype
Medical subject headings
Sleep Deprivation, Fatigue, Idiopathic Hypersomnia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pro Agility TestBehavioural

    The Pro Agility Test (20-yard shuttle run) evaluates change-of-direction speed. Participants started from the center point, ran 5 yards to the left, then 10 yards to the right, and finally 5 yards back to the center. The total distance was 18.28 meters, and the time to complete the sequence was recorded. Agility and RSA timings were recorded using a dual-beam electronic timing system (SmarTracks, Germany) with a sampling frequency of 1,000 Hz, positioned at the start and finish lines at hip level. This minimized human error and ensured millisecond precision.

  • Repeated-Sprint Ability (RSA) TestBehavioural

    The RSA test measures an athlete's ability to repeatedly produce maximal sprint efforts with limited recovery. This study employed 6 × 30-meter sprints with 20-second rest intervals between each sprint, a protocol commonly used in team sports to assess anaerobic endurance.

  • Rate of Perceived Exertion (RPE)Behavioural

    RPE was assessed using the Borg Scale (6-20), which captures the participant's subjective effort during physical activity. RPE was recorded immediately after each sprint during the RSA Test, and the average RPE score represented overall perceived exertion for the session.

Study groups in NCT07314645
Study groupRoleWhat they receive
No NapExperimentalNo Nap Conditions
Receives: Behavioral: Pro Agility Test; Behavioral: Repeated-Sprint Ability (RSA) Test; Behavioral: Rate of Perceived Exertion (RPE)
25 Min NapExperimental25 Min Nap Conditions
Receives: Behavioral: Pro Agility Test; Behavioral: Repeated-Sprint Ability (RSA) Test; Behavioral: Rate of Perceived Exertion (RPE)
45 Min NapExperimental45 Min Nap Conditions
Receives: Behavioral: Pro Agility Test; Behavioral: Repeated-Sprint Ability (RSA) Test; Behavioral: Rate of Perceived Exertion (RPE)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pro Agility Test

    Change-of-direction performance assessed using the Pro Agility Test (20-yard shuttle run).

    Participants will complete the test following each experimental condition (no nap, 25-minute nap, and 45-minute nap).

    The total time to complete the test will be recorded in seconds using an electronic timing system.

    Measured: Immediately after completion of each experimental condition, within a single testing session.

  2. Best sprint (s)

    Best sprint time measured during a repeated-sprint ability (RSA) test. Participants will perform a standardized RSA protocol consisting of repeated maximal sprints with fixed recovery intervals.

    The fastest single sprint time achieved during each RSA test will be recorded in seconds for each experimental condition (no nap, 25-minute nap, and 45-minute nap) using an electronic timing system.

    Measured: During each experimental testing session, immediately following the nap or no-nap condition.

  3. Total sprint (s)

    Total sprint time measured during a repeated-sprint ability (RSA) test. Participants will perform a standardized RSA protocol consisting of repeated maximal sprints separated by fixed recovery intervals.

    Total sprint time will be calculated as the sum of all sprint times completed during the RSA test for each experimental condition (no nap, 25-minute nap, and 45-minute nap) and recorded in seconds using an electronic timing system.

    Measured: During each experimental testing session, immediately following the nap or no-nap condition.

  4. 4. Rate of Perceived Exertipon (RPE)

    Perceived exertion assessed using the Borg 6-20 Rating of Perceived Exertion (RPE) scale.

    Participants will report their perceived exertion immediately after each sprint during the repeated-sprint ability test.

    The mean RPE score for each testing session will be calculated for each experimental condition.

    Measured: Immediately after completion of the repeated-sprint ability test in each experimental session.

  5. Hooper Index

    Subjective recovery status assessed using the Hooper Questionnaire. The questionnaire evaluates perceived fatigue, stress, muscle soreness, and sleep quality using standardized Likert-scale ratings.

    Participants will complete the Hooper Questionnaire following each experimental condition (no nap, 25-minute nap, and 45-minute nap), and a total Hooper Index score will be calculated for each session.

    Measured: After completion of each experimental session, following the nap or no-nap condition.

  6. Subjective Alertness (VAS)

    Subjective alertness will be assessed using a visual analogue scale (VAS). Participants will rate their perceived level of alertness on a 100-mm horizontal line anchored by "extremely sleepy" at one end and "fully alert" at the other.

    VAS assessments will be completed following each experimental condition (no nap, 25-minute nap, and 45-minute nap), and the distance from the left anchor will be recorded in millimeters as the alertness score.

    Measured: After completion of each experimental session, following the nap or no-nap condition.

Secondary outcomes (3)
  1. Pittsburgh Sleep Quality Index (PSQI)

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a validated self-report questionnaire consisting of 19 items that generate a global score ranging from 0 to 21, with higher scores indicating poorer subjective sleep quality.

    The PSQI will be administered once at baseline to characterize participants' habitual sleep quality prior to the experimental nap protocols.

    Measured: At baseline, prior to the first experimental session.

  2. Resting Heart Rate (HR)

    Resting heart rate will be measured in beats per minute (bpm) under standardized resting conditions.

    Heart rate will be recorded following a seated rest period prior to the experimental procedures to provide a baseline physiological characteristic of the participants.

    Measured: At baseline, prior to the first experimental session.

  3. Profile of Mood States (POMS)

    Mood states will be assessed using the Profile of Mood States (POMS) questionnaire.

    The POMS evaluates multiple dimensions of mood, including tension, depression, anger, vigor, fatigue, and confusion.

    Participants will complete the questionnaire under standardized conditions to characterize baseline psychological status prior to the nap interventions.

    Measured: At baseline, prior to the first experimental session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2026
  2. Study start10 May 2024
  3. Primary completion18 May 2024
  4. Study completion18 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07314645
Sponsor's protocol ID
2024/5635
Status last verified
Dec 2025
First submitted
21 Nov 2025
Last updated
2 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared. The study involves a small, homogeneous sample of adolescent athletes, and the dataset includes sensitive performance and psychophysiological measures. Sharing IPD could compromise participant confidentiality and was not included in the original informed consent.

Publications

  • Eken O, Oncu M, Kurtoglu A, Bozkurt O, Turkmen M, Aldhahi MI. The Acute Effects of 25- Versus 60-Minute Naps on Agility and Vertical Jump Performance in Elite Youth Soccer Players: The Role of Individual Chronotype. Life (Basel). 2025 Mar 7;15(3):422. doi: 10.3390/life15030422.

    PubMed 40141767

Questions about this trial

What is this clinical trial studying?

A study testing Pro Agility Test, Repeated-Sprint Ability (RSA) Test and Rate of Perceived Exertion (RPE) in people with Sleep Deprivation and Athletic Performance, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pro Agility Test (time frame: Immediately after completion of each experimental condition, within a single testing session.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07314645, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in